Veeva Systems Hosts Biopharma Summit in Europe
Veeva Systems will host the Veeva R&D and Quality Summit in Madrid, Spain, on June 4-5, 2025. The event will feature keynotes from leaders in the biopharma industry, including Bayer, Lonza, MSD, Novo Nordisk, Recipharm, and Teva. These sessions will explore how connected platforms and AI can enhance the development and manufacturing of new medicines, announced in a press release.
The summit will bring together over 1,400 industry professionals for more than 100 sessions, focusing on advancements in clinical, regulatory, safety, and quality sectors. A major highlight will be the introduction of Veeva AI, an initiative to integrate AI into the Veeva Vault Platform to automate critical functions and improve productivity.
Keynote speakers will discuss various topics, such as Bayer's approach to streamlining clinical infrastructure, Lonza's reshaping of quality management, and MSD's innovations in pharmacovigilance. Novo Nordisk will share insights on accelerating clinical trials, while Teva will highlight its data-driven strategies for navigating regulatory changes.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish like Life AI Weekly.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
ConcertAI Integrates ASCO Guidelines into AI Precision Suite
Transcripta Bio and Microsoft Research Collaborate on AI-Driven Gene Discovery
Skypoint Strengthens Leadership Team with Key Executive Appointments
Tevogen Bio Launches AI Initiative with Microsoft and Databricks
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read more